ImmVira’s Oncolytic Product MVR-T3011 Expanded to BCG-Naïve Bladder Cancer Patients for the First Time with Clinical Data Presented at the 2026 ASCO GU Conference

Author: Suzhou Yinuo Micropharmaceutical Technology Co., Ltd

Posted Date: